Leave your feedback Share Copy URL https://gographicsoutput.com/video/06136X2ghgy.html Email Facebook Twitter LinkedIn Pinterest Tumblr Share on Facebook Share on Twitter President Donald Trump’s acting attorney general signed an order reclassifying medical marijuana fro [IqB0DfB5gan] Health Updated on August 06, 2026 EDT — Published on August 06, 2026 EDT President Donald Trump’s acting attorney general signed an order reclassifying medical marijuana from Schedule I to Schedule III, a shift that does not legalize cannabis federally but changes how it’s regulated. The action by Todd Blanche speeds licensing for medical marijuana producers, allows tax deductions for licensed operators, and eases some research barriers. It also kicks off a reclassification process with a hearing slated for June. The move aligns with Trump’s push to expand access to medical treatment options, though critics say it amounts to a tax break for the industry and sends a confusing message about marijuana’s harms. Under Schedule III, cannabis would face looser restrictions; non-state medical products remain Schedule I. The order relies on a federal provision tied to international treaties to bypass a lengthy agency review. Supporters say it legitimizes programs in around 40 states; opponents warn of policy backlash and risks. Correction notes the spelling Marihuana. Like 👍 Subscribe 🔔 and stay informed. Visit NHENews.COM for more top headlines. sLqolQMXdWs r2D2HFQ700u ehkSDlGVfoi IvpbWLmUjKi
President Donald Trump’s acting attorney general signed an order reclassifying medical marijuana from Schedule I to Schedule III, a shift that does not legalize cannabis federally but changes how it’s regulated. The action by Todd Blanche speeds licensing for medical marijuana producers, allows tax deductions for licensed operators, and eases some research barriers. It also kicks off a reclassification process with a hearing slated for June. The move aligns with Trump’s push to expand access to medical treatment options, though critics say it amounts to a tax break for the industry and sends a confusing message about marijuana’s harms. Under Schedule III, cannabis would face looser restrictions; non-state medical products remain Schedule I. The order relies on a federal provision tied to international treaties to bypass a lengthy agency review. Supporters say it legitimizes programs in around 40 states; opponents warn of policy backlash and risks. Correction notes the spelling Marihuana. Like 👍 Subscribe 🔔 and stay informed. Visit NHENews.COM for more top headlines. sLqolQMXdWs r2D2HFQ700u ehkSDlGVfoi IvpbWLmUjKi